NEW FUNDING: Why Volition Capital Invested in Doing Things Media (DTM)  Read More

NEWS: Medly Pharmacy Announces Agreement to Acquire Pharmaca: Medly Pharmacy Announces Agreement to Acquire Pharmaca Expanding Free Same-Day Delivery to Include Health and Wellness Products  Read More

NEW FUNDING: Why We Invested in US Mobile  Read More

ASK JENNY ANYTHING: Volition Venture Partner Jenny Fleiss answers your questions: What Should I Expect During Investor Diligence?  Read More

SCALING SUCCESS PODCAST: Sean Cantwell interviews Paul Melchiorre for Scaling Success  Read More

Categories:
Categories:
Categories:
Categories:
Funding & Exit

Volition Capital, Founder Collective Focus on Stage- Specific Funding (Mass High Tech)

JustinWood
Volition

As the dollar size of the venture-capital industry shrinks, VC investors appear to be narrowing their focus.

Massachusetts’ venture economy saw two new firms launch in the past six months, both promising to focus exclusively on a specific stage in a startup’s life.  Firms have often staked out industry territory – investing only in life sciences or information technology, for example – but Volition Capital, which spun off from Fidelity Investments this month, is only interested in technology companies already bringing in $5 million to $50 million in revenue.  Founder Collective, which closed its first fund in November, looks only at seed-stage technology opportunities.

(click here for the full article)  Mass High Tech, By Galen Moore

Similar Articles